Dr. Li's research projects span breast and colorectal cancer early detection/screening, etiology, and survivorship. He has expertise in cancer epidemiology and experience in the design, leadership, and completion of studies of cancer. Currently, he is working on projects aimed at identifying novel biomarkers that could be used for the early detection of breast cancer, evaluating risk factors for different types of breast cancer, identifying predictors of poor outcomes among breast and colorectal cancer survivors, and assessing disparities in cancer stage, treatment and survival by race/ethnicity.
Dr. Christopher Li completed his MD at the University of California, San Francisco and his PhD in Epidemiology at the University of Washington. He is a Professor at Fred Hutchinson Cancer Research Center and is a Research Full Professor in the Department of Epidemiology at the University of Washington. His research projects span breast and colorectal cancer early detection/screening, etiology, and survivorship. He has expertise in cancer epidemiology and experience in the design, leadership, and completion of studies of cancer.